Baker Brothers Life Sciences LP, Director, 10% Owner at ACADIA PHARMACEUTICALS INC (ACAD), bought 1,562,500 shares at $40.00 ($62.5M) on 2019-09-20, disclosed to the SEC on 2019-09-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 68,475 | $2.7M | 4.4% |
| 2 | $40.00 | 1,494,025 | $59.8M | 95.6% |
| Total | $40.00 avg | 1,562,500 | $62.5M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |